CROI 2011: Studies Shed Further Light on Cardiovascular Disease among People with HIV
- Details
- Category: Cardiovascular Disease
- Published on Friday, 18 March 2011 00:00
- Written by Paul Dalton
HIV positive people are at higher risk for cardiovascular disease overall, compared with HIV negative individuals, according to findings from Kaiser Permanente presented this month at the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011). Other studies found that HIV positive people on ART with well-preserved immune function were not at greater risk, however, and that abacavir (Ziagen) was not linked to heart attacks.
CROI 2011: Low Vitamin D Levels Less Likely with Rilpivirine than Efavirenz
- Details
- Category: Approved HIV Drugs
- Published on Friday, 18 March 2011 00:25
- Written by Matt Sharp
HIV positive people who use antiretroviral regimens containing the investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) rilpivirine (TMC278) saw smaller changes in their vitamin D levels and were less likely to develop severe deficiency than people taking efavirenz, according to a presentation at the 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011) this month in Boston. 
CROI 2011: Immediate ART Improves Survival for HIV+ People with TB
- Details
- Category: Tuberculosis (TB)
- Published on Tuesday, 22 March 2011 00:00
- Written by Liz Highleyman
Tuberculosis patients who immediately start antiretroviral therapy are less likely to progress to AIDS or die, but among people with higher CD4 counts, waiting reduces the risk of IRIS, researchers reported at CROI 2011. 
CROI 2011: Acute Hepatitis C Treatment for HIV/HCV Coinfected People
- Details
- Category: HIV/HCV Coinfection
- Published on Monday, 21 March 2011 08:29
- Written by Liz Highleyman
About 65% of coinfected patients with HCV genotypes 1 or 4, and 81% with genotypes 2 or 3, achieved sustained response to interferon-based therapy started during acute infection, researchers reported at CROI 2011.
CROI 2011: Interactions of HIV Meds with HCV drugs Telaprevir and Boceprevir
- Details
- Category: Approved HCV Drugs
- Published on Tuesday, 22 March 2011 00:00
- Written by Liz Highleyman
New HCV antiviral drugs can interact with some antiretroviral drugs for HIV, but others are not affected and HIV/HCV coinfected patients can be treated successfully with minimal dose adjustments.
Web Design and Development by